Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Myo Plus

K-Number: K191179 · 2019-09-04

Decision Date2019-09-04
Product CodeGXY
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Myo Plus is a medical device manufactured by Otto Bock Healthcare Products GmbH. It received FDA 510(k) clearance on 2019-09-04 under approval number K191179. The device is classified under product code GXY. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Myo Plus?

Myo Plus is a medical device that received FDA 510(k) clearance on 2019-09-04. It is manufactured by Otto Bock Healthcare Products GmbH. The 510(k) number is K191179.

When was Myo Plus approved by the FDA?

Myo Plus received FDA 510(k) clearance on 2019-09-04, under approval number K191179.

What company makes Myo Plus?

Myo Plus is manufactured by Otto Bock Healthcare Products GmbH.

What is the FDA product code for Myo Plus?

The FDA product code for Myo Plus is GXY.

Other Devices by Otto Bock Healthcare Products GmbH

Related Devices (Code: GXY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.